TMEM97 and early-onset autosomal dominant Alzheimer disease: The consideration of the σ2-R/PGRMC1 complex as a key regulator of Aβ1-42 oligomer and apoE accumulation in the cell has led to the conclusion that it may be of clinical significance in the treatment of Alzheimer’s disease.